News
Tyson 2.0 Teams Up with Reborn Roots for a Heavyweight Touchdown in Rhode Island
LOS ANGELES – Celebrity Cannabis brands have tested markets from the Pacific Northwest to the Caribbean and one of the sector's most recognized names is now pushing into New England. Tyson 2.0 Inc. announced an exclusive licensing agreement with Reborn Roots LLC, bringing the brand's full product lineup to Rhode Island dispensaries for both adult-use ...
Ascend Wellness Reports Q2 2026 Financial Results
NEW YORK – Ascend Wellness Holdings Inc. reported its Q2 2026 financial results posting net revenue of $126.1 million, a 7.9% sequential increase from $116.9 million in Q1 2026. Retail revenue climbed 11.5% quarter-over-quarter to $92.7 million, accounting for 73.5% of total net revenue, up from 71.1% in the prior period. Wholesale revenue held near ...
Washington Has a Plan for Hemp-Derived Beverages. The Rest of the Hemp Industry Wants One Too.
LOS ANGELES - WASHINGTON – A bipartisan bill introduced in Congress this week would bring hemp-derived THC drinks under the same federal regulatory structure long used for alcohol. For an industry watching a federal ban deadline close in, the proposal offers something it has rarely seen: a concrete rulebook with political backing on both sides ...
Trulieve Completes Redomicile to Delaware
TALLAHASSEE – Trulieve Cannabis Corp. completed its redomiciliation from British Columbia, Canada, to the State of Delaware, following a shareholder vote and a Final Order from the British Columbia Supreme Court. The redomicile took effect when the necessary filings were made effective by The Diamond State. The ballot was decisive: 71,756,586 shares were cast in ...
PSYCH Symposium Rebrands as Mind Forward for Another London Event
LONDON – The organizers of Europe’s established psychedelic medicine conference have rebranded the platform and expanded its focus. The new identity, Mind Forward, will host a one-day symposium in London later this year. PSYCH has transitioned into Mind Forward after more than six years of programming centered on psychedelic research, policy and care. The shift ...
Organigram Reports Q3 Fiscal 2026 Financial Results
TORONTO – Organigram Global Inc. released its third-quarter fiscal 2026 results, showing the first full contribution from its recent European acquisition alongside continued strength in the Canadian market. The company reported higher sales and adjusted profitability for the period. Net revenue reached $105.8 million, up 49% from the same quarter a year earlier. Gross revenue ...
Curaleaf States Intention to Bid for Aurora Cannabis
STAMFORD – Curaleaf Holdings Inc. has publicly outlined plans to purchase all of the issued and outstanding common shares of Aurora Cannabis Inc., moving the proposal directly to shareholders after earlier private outreach. The announcement marks a notable step in cross-border consolidation within the Cannabis sector. In a statement, Curaleaf said it intends to offer ...
Vireo Growth Reports Q2 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported GAAP revenue of $209.3 million for the three months ended June 30, 2026, up 335% year-over-year from $48.1 million in Q2 2025, driven by the Eaze, Hawthorne Gardening Company, and Bridgewell Agribusiness transactions, all of which closed during the quarter. Total Cannabis revenue reached $175.8 million for the period, ...
Senate Votes to Extend Hemp THC Ban Timeline
WASHINGTON – The U.S. Senate voted to table a bipartisan amendment that would have kept a federal hemp THC ban on schedule for November. By a 61-32 margin, the chamber defeated a proposal from Sen. Ted Budd (R) that would have stripped a delay provision from a continuing resolution (CR) funding the federal government through ...
Puerto Rico Governor Orders Psychedelics Research
SAN JUAN – Puerto Rico’s governor has directed the territory’s health department to examine the practical steps needed to advance clinical research into emerging therapies, including certain psychedelic compounds. The move positions a commonwealth to explore regulated trials aimed at serious mental health and substance-use challenges. Governor Jenniffer González-Colón signed Executive Order 2026-037, instructing the ...
Vireo Growth Closes Colorado Retail Deal, Secures Bank-Led Credit Line
MINNEAPOLIS – Vireo Growth Inc. announced it had received all required regulatory approvals and formally closed its acquisition of certain Colorado retail assets from PharmaCann Inc. Additionally, the company disclosed a senior secured asset-based revolving credit facility arranged through Bank of Montreal. The PharmaCann transaction, first announced in December 2025, transferred 17 operational dispensaries, along ...
Trulieve Reports Q2 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. released its second-quarter 2026 financial results, reflecting a period that included the deconsolidation of Harvest operations, recognition from TIME magazine, and the company's listing on the New York Stock Exchange. The medical Cannabis operator outlined revenue, margins and cash generation while noting several operational and strategic steps. Revenue for the ...
NY Cannabis Market Gains New Outdoor Sales Path
NEW YORK – New York Governor Kathy Hochul signed legislation that expands the ways licensed microbusinesses and dispensaries can sell Cannabis products at approved community events. The measure aims to give smaller operators more direct access to consumers while reinforcing the state’s regulated market. The Assembly Bill A11217 clarifies that vertically integrated microbusinesses can fully ...
High Tide Closes BMO Credit Facility, Issues Q3 Guidance
CALGARY – High Tide Inc. closed its C$40 million senior secured credit facilities with Bank of Montreal (BMO), replacing an existing arrangement with ConnectFirst Credit Union and substantially lowering the company's cost of capital. The transaction marks the first time the Cannabis operator has secured a senior lending relationship with a Big Five Canadian chartered ...
LEEF Brands Reports Q2 2026 Financial Results
VANCOUVER – LEEF Brands Inc. posted gross profit up 62% and gross margin that nearly doubled year-over-year, even as top-line revenue fell by 16%. Net revenue reached $7.3 million, down from $8.7 million in Q2 2025, primarily reflecting lower volumes while the company operated with a temporary biomass gap between 2025 and 2026 harvests from ...
ACT LAB Enters NJ Cannabis Market with Sriven Labs Acquisition
TRENTON – ACT LAB, a Cannabis and hemp testing and compliance laboratory network, announced its entry into New Jersey through the acquisition of Sriven Labs (SV Labs – NJ), a licensed and ISO-accredited testing laboratory that has served the state's regulated operators since its founding. The New Jersey Cannabis Regulatory Commission approved the deal. The ...
Cresco Labs Reports Q2 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its second-quarter 2026 financial results, offering a clear look at how the multistate operator performed through the end of June. The company, known for its branded products and Sunnyside retail stores, reported progress in several markets while noting a leadership change at the finance desk. Revenue reached $173 million ...
Curaleaf Reports Q2 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted second-quarter 2026 revenue of $340.1 million, up 10% year-over-year and 5% sequentially; with net income from continuing operations of $12.5 million, or $0.05 per share, reversing a $48.1 million loss in the prior-year period. Gross profit landed at $169.9 million at a 50% margin, up 70 basis points year-over-year. ...
Aurora Cannabis Reports Q1 FY 2027 Financial Results
EDMONTON – Aurora Cannabis Inc. released its first-quarter fiscal 2027 results, covering the period ended June 30, 2026. The Canadian medical Cannabis company highlighted growth in its international segment alongside a smaller overall revenue figure compared with the year-earlier period. Net revenue reached $67.6 million, down 9% from $74.1 million a year ago. The decline ...
GTI Reports Q2 2026 Financial Results
CHCAGO – Green Thumb Industries Inc. reported Q2 2026 revenue of $306.7 million, clearing Wall Street's consensus estimate of $298.99 million by roughly $8 million. The result represented a 4.6% year-over-year gain, driven primarily by adult-use sales growth in Minnesota alongside continued performance in Connecticut, Florida, and Ohio. GAAP net income swung to $4.9 million, ...
Verano Reports Q2 2026 Financial Results
CHICAGO – Verano Holdings Corp. posted net revenue of $218 million for the three months ended June 30, 2026, up 8% year-over-year from $202 million in Q2 2025, and up 5% sequentially from $208 million in Q1 2026. Gross profit came in at $100 million, or 46% of revenue – a meaningful step back from ...
RYTHM Reports Q2 2026 Financial Results
ROLLING MEADOWS – RHYTHM, Inc. posted revenue from continuing operations of $23 million in the second quarter of 2026, a 73% sequential increase that cleared management's own guidance of 65% growth. For context. Total revenue across the same period one year earlier was $2 million – a year-over-year comparison that captures how fundamentally RYTHM's business ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The final days of July and the opening of August delivered a concentrated burst of news that touched labor, capital markets, federal regulation, and cross-border insolvency. A historic labor settlement, a one-company M&A wave, a federal regulatory milestone for psychedelics, a bankruptcy filing across the border, and a round of Q2 earnings ...
MJBowl Adds Colorado for Its Second Year
LOS ANGELES – The MJBowl, the Cannabis product competition co-presented by MJBizCon and professional review platform Budist, is returning for its second year, with Colorado joining California and New York in the competition pool for the first time. Registration opens today, August 3, running through September 30, 2026. Entry costs $250 per product through August ...
FDA Issues Final Guidance on Psychedelic Drug Trials
SILVER SPRING – The FDA published its final guidance titled "Psychedelic Drugs: Considerations for Clinical Investigations" in the Federal Register, finalizing a draft that first appeared in June 2023. Issued by the Center for Drug Evaluation and Research, the document gives sponsors general considerations for developing compounds including psilocybin, LSD, and MDMA as treatments for ...
